Article Text

Download PDFPDF
Childhood immunisation: what is the future?
  1. Andrew J Pollard
  1. Correspondence to:
    Dr Andrew J Pollard
    Department of Paediatrics, University of Oxford, Level 2, Children’s Hospital, Oxford OX3 9DU, UK; andrew.pollard{at}paediatrics.ox.ac.uk

Footnotes

  • AJP acts as chief investigator for clinical trials conducted on behalf of Oxford University sponsored by vaccine manufacturers (Sanofi-Pasteur MSD, Novartis Vaccines, GlaxoSmithKline Biologicals, Sanofi-Pasteur and Wyeth Vaccines), and has received assistance from manufacturers to attend scientific meetings. Industry-sourced consultancies and honoraria for lecturing or writing are paid directly to an independent charity or an educational fund held by the Department of Paediatrics, University of Oxford. AJP is also an inventor on a patent application in the area of MenB vaccines, and a Jenner Institute investigator.

View Full Text

Statistics from Altmetric.com

Footnotes

  • AJP acts as chief investigator for clinical trials conducted on behalf of Oxford University sponsored by vaccine manufacturers (Sanofi-Pasteur MSD, Novartis Vaccines, GlaxoSmithKline Biologicals, Sanofi-Pasteur and Wyeth Vaccines), and has received assistance from manufacturers to attend scientific meetings. Industry-sourced consultancies and honoraria for lecturing or writing are paid directly to an independent charity or an educational fund held by the Department of Paediatrics, University of Oxford. AJP is also an inventor on a patent application in the area of MenB vaccines, and a Jenner Institute investigator.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Précis
    BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health